Young, Christina B. https://orcid.org/0000-0001-9535-2137
Johns, Emily
Kennedy, Gabriel
Belloy, Michael E.
Insel, Philip S.
Greicius, Michael D.
Sperling, Reisa A.
Johnson, Keith A.
Poston, Kathleen L.
Mormino, Elizabeth C.
,
,
Funding for this research was provided by:
National Institute of Aging (K99AG071837)
National Institute of Aging (K99AG075238)
National Institute of Aging (P30AG066515)
National Institute of Aging (K01AG051718)
National Institute of Aging (P01AG036694)
National Institute of Aging (P50AG005134)
National Institute of Aging (U24AG074855)
National Institute of Neurological Disorders and Stroke (R01NS115114)
Alzheimer's Association (AARFD-21-849349)
Alzheimer's Association (AARF-20-683984)
Article History
Received: 12 October 2022
Accepted: 14 December 2022
First Online: 4 January 2023
Declarations
:
: All A4 participants completed written informed consent before participation. All ADNI participants provided written informed consent in compliance with local IRBs.
: Not applicable.
: KLP received consulting fees from CuraSen Therapeutics Inc. ECM is a paid consultant for Roche, Genentech, and Eli Lilly. All other authors have no disclosures relevant to the manuscript.